This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Valorisation Hsj, Limited Partnership, Valorisation-Recherche, Limited Partnership. Active years: 2018.
Company Filing History:
1 out of 12 
1 out of 43 Years Active: 2018
Title: Caroline Alfieri: Innovator in Peptide Technology
Introduction
Caroline Alfieri is a notable inventor based in Dollard-des-Ormeaux, Canada. She has made significant contributions to the field of peptide technology, particularly in relation to the Epstein-Barr virus (EBV). Her innovative work has the potential to impact immunization and vaccine development.
Latest Patents
Caroline holds a patent for "Antigenic epitopes from EBV gp350/220 and uses thereof." This invention relates to a peptide that comprises specific amino acid sequences designed to bind to monoclonal antibodies. The peptide may be useful for inducing the production of neutralizing antibodies against gp350-expressing herpesviruses, such as EBV. This technology could be instrumental in immunizing animals against these viruses and in detecting neutralizing antibodies in samples.
Career Highlights
Throughout her career, Caroline has worked with various organizations, including Valorisation Hsj, Limited Partnership and Valorisation-Recherche, Limited Partnership. Her expertise in peptide technology has positioned her as a valuable contributor to the scientific community.
Collaborations
Caroline has collaborated with notable colleagues, including Jing Hu and Jurgen Sygusch. These partnerships have further enhanced her research and development efforts in the field of immunology.
Conclusion
Caroline Alfieri's work in peptide technology represents a significant advancement in the fight against herpesviruses. Her innovative patent and collaborations highlight her dedication to improving immunization strategies.